Triterpene derivative and agent for preventing or treating chronic hepatitis c
AssigneeMeiji Seika Pharma Co., Ltd.
InventorsMakoto Ishikawa, Shigeki Suzuki, Makoto Aoki, Nobuto Minowa, Kokichi Suzuki
Life of this patent
Estimating the term…
Loading patent…
AssigneeMeiji Seika Pharma Co., Ltd.
InventorsMakoto Ishikawa, Shigeki Suzuki, Makoto Aoki, Nobuto Minowa, Kokichi Suzuki
Estimating the term…
Provided are a triterpene derivative represented by a general formula (I), a pharmaceutically acceptable salt thereof, and an agent for preventing or treating chronic hepatitis C comprising the triterpene derivative or the salt as an active ingredient: [in the formula (I), R1 represents a carboxyl group, a hydroxymethyl group, —CH2OSO3H, or and R2 represents —OR3 or —O— (CH2) m-OR4, where R3 represents a benzyl group which may be substituted with a hydroxymethyl group, a dimethylaminomethyl group, a phenylaminomethyl group, a morpholinomethyl group, a carboxyl group, or a formyl group, a C1-6 alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, or a hydroxy C1-6 alkyl group, R4 represents a phenyl group which may be substituted with a carboxyl group, and m represents an integer of 1 to 3, with the proviso that a case where R1 is —CH2OH, and R3 is a C1-6 alkyl group, a C2-6 alkenyl group, or a benzyl group is excluded].
A triterpene derivative represented by a general formula (I) or a pharmaceutically acceptable salt thereof:
A triterpene derivative represented by a general formula (I) or a pharmaceutically acceptable salt thereof:
A triterpene derivative represented by a general formula (I) or a pharmaceutically acceptable salt thereof:
A triterpene derivative represented by a general formula (I) or a pharmaceutically acceptable salt thereof:
A triterpene derivative represented by a general formula (I) or a pharmaceutically acceptable salt thereof:
Dependencies are inferred from the claim text.